What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His main research concerns Vaccination, Adverse effect, Pediatrics, Immunology and Surgery.
His biological study spans a wide range of topics, including Immunization, Incidence, Public health and Risk factor.
His Adverse effect study combines topics from a wide range of disciplines, such as Vaccine safety and Intensive care medicine.
His studies in Pediatrics integrate themes in fields like Medical record, Influenza vaccine and Measles-Mumps-Rubella Vaccine.
His studies deal with areas such as Global health, Internal medicine and Brentuximab vedotin as well as Surgery.
As part of one scientific family, he deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Phases of clinical research and Regimen.
His most cited work include:
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma (985 citations)
- Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland (657 citations)
- Impact of anti-vaccine movements on pertussis control: the untold story (504 citations)
What are the main themes of his work throughout his whole career to date?
Robert T. Chen mainly focuses on Vaccination, Internal medicine, Immunology, Pediatrics and Adverse effect.
His Vaccination research is multidisciplinary, incorporating elements of Epidemiology, Immunization, Incidence and Public health.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Surgery and Oncology.
His Immunology study frequently draws connections to other fields, such as Virology.
Robert T. Chen studied Pediatrics and Diphtheria that intersect with Tetanus.
His Adverse effect study incorporates themes from Clinical trial, Vaccine safety and Intensive care medicine.
He most often published in these fields:
- Vaccination (38.07%)
- Internal medicine (28.10%)
- Immunology (23.26%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (28.10%)
- Oncology (15.11%)
- Brentuximab vedotin (12.99%)
In recent papers he was focusing on the following fields of study:
Robert T. Chen spends much of his time researching Internal medicine, Oncology, Brentuximab vedotin, Lymphoma and Surgery.
In Internal medicine, Robert T. Chen works on issues like Gastroenterology, which are connected to Confidence interval, Adverse effect, Anemia, Leukopenia and Performance status.
He usually deals with Adverse effect and limits it to topics linked to Vaccine safety and Environmental health.
His research in Oncology intersects with topics in Pembrolizumab, Chemotherapy and Hodgkin lymphoma.
His study on Brentuximab vedotin is covered under Immunology.
His work carried out in the field of Lymphoma brings together such families of science as Cancer, Cancer research and Hematopoietic stem cell transplantation.
Between 2014 and 2021, his most popular works were:
- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma (290 citations)
- Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (193 citations)
- Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. (152 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary areas of study are Internal medicine, Brentuximab vedotin, Oncology, Gastroenterology and Lymphoma.
Internal medicine is closely attributed to Surgery in his research.
The concepts of his Brentuximab vedotin study are interwoven with issues in Anaplastic large-cell lymphoma and Antibody-drug conjugate.
His work deals with themes such as Malignancy, Transplantation and Hodgkin lymphoma, which intersect with Oncology.
As part of the same scientific family, he usually focuses on Gastroenterology, concentrating on Adverse effect and intersecting with Nausea.
Lymphoma is a subfield of Immunology that Robert T. Chen studies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
